These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 27277113)
1. Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype. Sun WY; Kim HM; Jung WH; Koo JS J Transl Med; 2016 Jun; 14(1):168. PubMed ID: 27277113 [TBL] [Abstract][Full Text] [Related]
2. Expression of serine and glycine-related enzymes in phyllodes tumor. Kwon JE; Kim DH; Jung WH; Koo JS Neoplasma; 2014; 61(5):566-78. PubMed ID: 25030440 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. Kim SK; Jung WH; Koo JS PLoS One; 2014; 9(6):e101004. PubMed ID: 24979213 [TBL] [Abstract][Full Text] [Related]
4. Expression of Autophagy-Related Proteins in Different Types of Thyroid Cancer. Kim HM; Kim ES; Koo JS Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257096 [TBL] [Abstract][Full Text] [Related]
5. Expression levels of serine/glycine metabolism-related proteins in triple negative breast cancer tissues. Noh S; Kim DH; Jung WH; Koo JS Tumour Biol; 2014 May; 35(5):4457-68. PubMed ID: 24390667 [TBL] [Abstract][Full Text] [Related]
6. Glycolysis-related protein expression in thyroid cancer. Nahm JH; Kim HM; Koo JS Tumour Biol; 2017 Mar; 39(3):1010428317695922. PubMed ID: 28347233 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of serine and glycine metabolism-related proteins between follicular neoplasm and Hürthle cell neoplasm. Kim HM; Kim ES; Koo JS Int J Clin Exp Pathol; 2018; 11(4):2064-2071. PubMed ID: 31938313 [TBL] [Abstract][Full Text] [Related]
8. Expression of glutamine metabolism-related proteins in thyroid cancer. Kim HM; Lee YK; Koo JS Oncotarget; 2016 Aug; 7(33):53628-53641. PubMed ID: 27447554 [TBL] [Abstract][Full Text] [Related]
9. Expression of proteins related to autotaxin-lysophosphatidate signaling in thyroid tumors. Shin E; Koo JS J Transl Med; 2019 Aug; 17(1):288. PubMed ID: 31455351 [TBL] [Abstract][Full Text] [Related]
10. Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma. Sun WY; Jung WH; Koo JS Tumour Biol; 2016 Jun; 37(6):8197-207. PubMed ID: 26715280 [TBL] [Abstract][Full Text] [Related]
11. Expression of epithelial membrane protein (EMP) 1, EMP 2, and EMP 3 in thyroid cancer. Kim EK; Koo JS Histol Histopathol; 2022 Jan; 37(1):51-61. PubMed ID: 34617578 [TBL] [Abstract][Full Text] [Related]
12. Site-specific metabolic phenotypes in metastatic breast cancer. Kim HM; Jung WH; Koo JS J Transl Med; 2014 Dec; 12():354. PubMed ID: 25496516 [TBL] [Abstract][Full Text] [Related]
13. Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma. Kim YH; Jung WH; Koo JS Tumour Biol; 2014 Oct; 35(10):10381-93. PubMed ID: 25053597 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Jung YY; Yoo JH; Park ES; Kim MK; Lee TJ; Cho BY; Chung YJ; Kang KH; Ahn HY; Kim HS Pathol Res Pract; 2015 Feb; 211(2):162-70. PubMed ID: 25468810 [TBL] [Abstract][Full Text] [Related]
15. BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer. Fraser S; Go C; Aniss A; Sidhu S; Delbridge L; Learoyd D; Clifton-Bligh R; Tacon L; Tsang V; Robinson B; Gill AJ; Sywak M World J Surg; 2016 Jul; 40(7):1618-24. PubMed ID: 27138882 [TBL] [Abstract][Full Text] [Related]
16. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status. Paskaš S; Janković J; Marečko I; Išić Denčić T; Tatić S; Cvejić D; Savin S Otolaryngol Head Neck Surg; 2014 Feb; 150(2):201-9. PubMed ID: 24255086 [TBL] [Abstract][Full Text] [Related]
18. Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience. Gouveia C; Can NT; Bostrom A; Grenert JP; van Zante A; Orloff LA JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1164-70. PubMed ID: 24030686 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia controls the expression of genes responsible for serine synthesis in U87MG cells on ERN1-dependent manner. Sliusar MY; Minchenko DO; Khita OO; Tsymbal DO; Viletska YM; Luzina OY; Danilovskyi SV; Ratushna OO; Minchenko OH Endocr Regul; 2023 Jan; 57(1):252-261. PubMed ID: 37823569 [No Abstract] [Full Text] [Related]
20. Inhibition of signaling protein ERN1 increases the sensitivity of serine synthesis gene expressions to glucose and glutamine deprivations in U87MG glioblastoma cells. Minchenko OH; Sliusar MY; Khita OO; Minchenko DO; Viletska YM; Halkin OV; Levadna LO; Cherednychenko AA; Khikhlo YP Endocr Regul; 2024 Jan; 58(1):91-100. PubMed ID: 38656254 [No Abstract] [Full Text] [Related] [Next] [New Search]